Cargando…

Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis

Detalles Bibliográficos
Autores principales: O'Brien, Morgan, Forde, Patrick, Power, Derek, Soden, Declan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288409/
http://dx.doi.org/10.1186/2051-1426-2-S3-P116
_version_ 1782351966536466432
author O'Brien, Morgan
Forde, Patrick
Power, Derek
Soden, Declan
author_facet O'Brien, Morgan
Forde, Patrick
Power, Derek
Soden, Declan
author_sort O'Brien, Morgan
collection PubMed
description
format Online
Article
Text
id pubmed-4288409
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42884092015-01-15 Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis O'Brien, Morgan Forde, Patrick Power, Derek Soden, Declan J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288409/ http://dx.doi.org/10.1186/2051-1426-2-S3-P116 Text en Copyright © 2014 Brien et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
O'Brien, Morgan
Forde, Patrick
Power, Derek
Soden, Declan
Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis
title Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis
title_full Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis
title_fullStr Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis
title_full_unstemmed Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis
title_short Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis
title_sort electrochemotherapy and inducible t cell co-stimulator (icos) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288409/
http://dx.doi.org/10.1186/2051-1426-2-S3-P116
work_keys_str_mv AT obrienmorgan electrochemotherapyandinducibletcellcostimulatoricosantibodytherapyanovelcombinationaltherapyfortheenhancedtreatmentincancersofpoorprognosis
AT fordepatrick electrochemotherapyandinducibletcellcostimulatoricosantibodytherapyanovelcombinationaltherapyfortheenhancedtreatmentincancersofpoorprognosis
AT powerderek electrochemotherapyandinducibletcellcostimulatoricosantibodytherapyanovelcombinationaltherapyfortheenhancedtreatmentincancersofpoorprognosis
AT sodendeclan electrochemotherapyandinducibletcellcostimulatoricosantibodytherapyanovelcombinationaltherapyfortheenhancedtreatmentincancersofpoorprognosis